{"pageProps":{"source":{"compiledSource":"var h=Object.defineProperty,p=Object.defineProperties;var u=Object.getOwnPropertyDescriptors;var s=Object.getOwnPropertySymbols;var o=Object.prototype.hasOwnProperty,r=Object.prototype.propertyIsEnumerable;var l=(e,t,a)=>t in e?h(e,t,{enumerable:!0,configurable:!0,writable:!0,value:a}):e[t]=a,n=(e,t)=>{for(var a in t||(t={}))o.call(t,a)&&l(e,a,t[a]);if(s)for(var a of s(t))r.call(t,a)&&l(e,a,t[a]);return e},c=(e,t)=>p(e,u(t));var d=(e,t)=>{var a={};for(var i in e)o.call(e,i)&&t.indexOf(i)<0&&(a[i]=e[i]);if(e!=null&&s)for(var i of s(e))t.indexOf(i)<0&&r.call(e,i)&&(a[i]=e[i]);return a};const layoutProps={},MDXLayout=\"wrapper\";function MDXContent(a){var i=a,{components:e}=i,t=d(i,[\"components\"]);return mdx(MDXLayout,c(n(n({},layoutProps),t),{components:e,mdxType:\"MDXLayout\"}),mdx(\"h1\",null,\"NCCID Project Summaries\"),mdx(\"p\",null,`The core of the NCCID initiative is to provide value to the public in\nresponse to the COVID-19 crisis. For this reason, NCCID wishes to share\ninformation on how the data is being utilised by approved institutions\nand researcherts, to inform the wider community of patients, staff and\ninterested public.`),mdx(\"p\",null,\"Below is a list of the projects currently ongoing.\"),mdx(\"h2\",null,\"University College London\"),mdx(\"p\",null,`University College London plans to store the NCCID data in a highly\nsecure XNAT repository to enable imaging-based research at UCL Centre\nfor Medical Image Computing (CMIC). In particular, researchers at CMIC\nwill use these data to build artificial intelligence models to\nautomatically detect COVID-19 patients based on their CT or X-ray\nimages, such that, in the future, these images can be screened\nautomatically before doctors read them. This will significantly save\ntime in managing future outbreaks. The research also involves building\ncomputational models to analyse the outcomes for those with confirmed\nCOVID-19 diagnosis, predicting best management for individual patients.\nThese predictions may shorten their hospital stay, reduce complications\nand even save lives. Finally, the project will investigates methods to\ndeploy these developed models to local hospitals quickly and safely.`),mdx(\"h2\",null,\"University of Cambridge\"),mdx(\"p\",null,`It is strongly believed that early detection of COVID-19 and\nintervention leads to lower Covid-19 mortality because it enables\ndisease treatment via oxygen therapy and control of spread via\nisolation. The diagnosis of COVID-19 must be confirmed by\nreverse-transcription polymerase chain reaction (RT-PCR) or gene\nsequencing for respiratory or blood specimens. However, testing the\ngeneral population is proving to be very challenging because of various\nreasons including limitations of sample collection and transportation,\nkit performance and availability, limitations in capacity, etc.`),mdx(\"p\",null,`Chest scans could include x-rays, CT and MRI scans. Chest CT scans are\nused to examine lung tissues and often used for further investigation\nafter an abnormal chest x-ray. Chest MRI scans provide a detailed\npicture of the chest wall, heart, and blood vessels. These scans are\ncarried out routinely for a variety of medical reasons, including\npreparation for surgery, annual follow-ups, accident and emergency, etc.\nThe creation of computer systems that can automatically process these\nscans to detect and identify signs of Covid-19 can provide added value\nfor the NHS with no significant additional burden on staff, resources,\noperational costs, etc. The development of these systems require the\nimplementation of cutting-edge image processing and artificial\nintelligence technologies.`),mdx(\"p\",null,`X-ray images and CT scans can also be useful in monitoring the\nprogression of Covid-19 patients as they can reveal if their lungs are\nfilled with sticky mucus that can lead to breathing problems and provide\na benchmark for comparisons with previous scans.`),mdx(\"p\",null,`This project aims to find the visual signatures of Covid-19, as they\nappear in chest scans, that can lead to accurate diagnostic and\nprognosis for use in hospital settings. Automated imaging algorithms,\naided by advanced artificial intelligence techniques, can detect some of\nthe abnormal features appearing in these scans, such as ground glass\npatterned areas, Ground glass, Crazy paving, Vascular dilatation,\nTraction Bronchiectasis. These features are generally not specific to\nCovid-19 and could be seen with other infections. Hence, it is important\nto develop AI techniques to aid the imaging analysis to increase the\naccuracy of diagnostic.`),mdx(\"h2\",null,\"University of Bradford\"),mdx(\"p\",null,`Coronavirus Disease 2019 (COVID-19) is highly contagious, and severe\ncases can lead to pneumonia and ultimately death. The diagnosis can be\nconfirmed by laboratory testing; however, the test has low sensitivity\nwhich leads to late diagnosis and treatment. Chest X-rays and CT scans\nprovide valuable diagnostic and monitoring information that can\ncomplement the laboratory and clinical data. In this project, we propose\nto develop an open-source artificial intelligence tool that combines\nchest imaging data and clinical data to support the diagnosis, triaging\nand prognosis for COVID-19 in the UK. This will make clinical decisions\nmore efficient, accurate, timely, and potentially cheaper, leading to\nbetter patient outcomes.`),mdx(\"h2\",null,\"Aidence\"),mdx(\"p\",null,`Chest CT scans are used in hospitals across the globe to image the\nseverity of COVID-19 lung involvement and guide the appropriate patient\nmanagement. Artificial intelligence (AI) designed for radiologists can\nincrease the speed of reporting on these scans and support timely\npatient triaging.`),mdx(\"p\",null,`Aidence has set-up an international consortium, ICOVAI, to create an AI\nsolution for COVID-19 on chest CTs. The consortium is a collaboration\nbetween clinical centers, hospitals, AI companies, and distribution\npartners.`),mdx(\"p\",null,`ICOVAI's AI solution will automatically detect COVID-19 on chest CTs and\nassess the extent of lung tissue affected. Its quantitative analysis can\nbe used to guide hospital management, such as bed capacity on wards, or\npredicting the need for ICU care.`),mdx(\"p\",null,`The consortium aims to reduce the workload and pressure that the medical\nstaff are facing during the pandemic. The software will be particularly\nuseful when test kits are absent or inconclusive, and when radiologists\nare unavailable or lack specific COVID-19 training.`),mdx(\"p\",null,`To train a well-performing model, ICOVAI is using high-quality datasets\nfrom diverse CT scanners, hospitals, and countries. The patient data is\nanonymised and processed in line with the GDPR. The product will comply\nwith the Medical Device Regulation (MDR), 2017/745, to ensure clinical\nsafety and quality.`),mdx(\"p\",null,`The AI solution will be made available not-for-profit for the NHS and\nEuropean hospitals. The project is backed by the EU.`),mdx(\"h2\",null,\"City Data Science Institute\"),mdx(\"p\",null,`The City Data Science Institute are using the NCCID dataset to develop\nartificial intelligence systems that offer explainable decision making.\nMore specifically, we are investigating the key radiological findings of\nCovid-19, how this can change over time, and how this differs from other\ndisease findings upon a chest X-ray. Using state-of-the-art generative\nnetworks, we aim to learn more about the Covid-19 disease process and\nfacilitate medical decision making.`),mdx(\"p\",null,`The chest X-ray is a readily available investigation and is useful in\nthe identification, severity assessment and monitoring of Covid-19. It\nis more readily available than CT scanning and able to exclude other\nimportant conditions that may present. The use of AI to assess chest\nX-rays can facilitate medical staff and improve patient outcomes.`),mdx(\"p\",null,`We have begun using a particular type of artificial intelligence model\nthat is able to learn what an X-ray should appear like if it were to be\nhealthy or more diseased. This will help the research community learn\nabout subtle disease features and can contribute to more accurate and\nquicker automatic diagnostics. One of our main goals is for our system\nto offer a counterfactual explanation as to why the artificial\nintelligence has made certain decisions. This is vital in developing\nsafe and effective AI.`),mdx(\"h2\",null,\"Medical Analytica Ltd\"),mdx(\"p\",null,`To test, evaluate and further finetune a software which can\nautomatically analyse Chest X-ray images to identify absence or presence\nof features of COVID-19 infection. The software can detect other lung\nconditions such as pneumonia caused by viral or bacterial infections.\nThe software is being further developed to identify other key conditions\nsuch as lesion and enlarged heart. The software utilises a number of\nmathematical models for image analysis and is capable of offering a high\nconfidence classification with minimum false positives or false\nnegatives.`),mdx(\"p\",null,`Ultimate objective is integrating it into the NHS radiology reporting\nworkflow to provide a prompt computer aided prediction alongside the\nradiologist's own report. By providing an extra layer of support to the\nclinical team, patient triage and access to appropriate treatment can be\nspeed up. Saving time, resources and most importantly, improving patient\nexperience.`),mdx(\"p\",null,`Other application of the software is to provide preliminary / indicative\nprediction to the primary care team in remote locations and community\nhospitals to assist in identifying in the community cases which may need\nurgent specialist attention in main hospitals.`),mdx(\"h2\",null,\"Universities of Brighton, Oxford, Glasgow, Lincoln and Sheffield\"),mdx(\"p\",null,`Members of this collaboration were instrumental in winning first place\nin\n'`,mdx(\"a\",n({parentName:\"p\"},{href:\"https://devpost.com/software/europa-mapp-predicting-stopping-covid19-waves-pandemics\"}),\"Coronahackathon\"),`'\nApril 2020, for the development of Machine Learning (ML) and Artificial\nIntelligence (AI) to predict patients with SARS-CoV-2 virus using full\nblood count results. SARS-CoV-2 positive patients exhibit a\ncharacteristic change in different parameters measured in simple and\nrapid blood tests to a high accuracy, predicting the virus in regular\nwards (93-94%) and those in the community (80-86%).`),mdx(\"p\",null,`Our project will validate these initial results and enable use in\ncurrent hospital practice to screen patients and identify those needing\nfull diagnosis for SARS-CoV-2. Expertise in chest images, blood science\nand modelling ML and AI will develop an innovative tool to upscale\nscreening to identify individuals for full rt-PCR testing of the virus\npotentially up to one week earlier than rt-PCR, which will allow much\nfaster release of the country (and the world) from lockdown, protection\nagainst future waves and future pandemics.`),mdx(\"h2\",null,\"Ashford and St Peter's Hospitals NHS Foundation Trust\"),mdx(\"p\",null,`Chest X-rays are often one of the first tests used to help guide doctors\nwith deciding how likely a patient is to have COVID-19 and also how\nsevere the infection is. We are aiming to see how accurate chest X-rays\nare for detecting COVID-19 and telling doctors how severe the disease\nis. We plan to answer this by having doctors specialising in X-rays\nassess chest X-rays of patients in the national COVID-19 imaging\ndatabase and then compare this assessment to clinical details, such as\nif they had COVID-19 and how well they did in hospital. We hope this\nwill give us a better understanding of chest X-ray accuracy in COVID-19\nand appearances that are linked to COVID-19 or more severe infection. We\nalso additionally aim to use Neural networks (advanced computational\nalgorithms) on the chest X-rays in the database to see if these can be\nused to automatically detect COVID-19 in chest X-rays. This research\nwill hopefully one day help with the development of clinical algorithms\nand technology that can be used to speed up chest X-ray assessment for\nCOVID-19.`),mdx(\"h2\",null,\"Behold.ai\"),mdx(\"p\",null,mdx(\"a\",n({parentName:\"p\"},{href:\"https://behold.ai/\"}),\"Behold.ai\"),` is currently operating existing services\nwithin the NHS for the triage of chest X-rays based on the presence of\nabnormalities, as determined by artificial intelligence algorithms. In\nthis study Behold.ai aims to achieve two key goals.`),mdx(\"p\",null,`First, we aim to validate that an algorithm developed for the general\ndetection of abnormalities on plain-film chest X-rays can identify novel\nforms of abnormality (such as COVID-19) despite being developed prior to\nthat pathology's initial presentation (in this case, prior to February\n2020). We propose that this will show that the use of existing AI-based\npatient triage can assist healthcare systems in the efficient use of\nresource and radiological capacity during high stress periods such as\npandemic flu, even when novel pathologies are present.`),mdx(\"p\",null,`Secondly, in recognition of the increased utilisation of AI across\nhealthcare sectors, we aim to establish a set of best practices for\nrapidly and regularly updating clinically deployed algorithms in order\nto enable efficient 'learning' of the characteristics of novel\npathologies. This will be validated by the ability of existing chest\nX-ray models to learn the characteristics of COVID-19 as demonstrated in\nthe NCCID. We suggest that this work will ensure that the implementation\nof AI into health systems improves future pandemic preparedness as well\nas maximising responsiveness to population health.`),mdx(\"h2\",null,\"The Royal Surrey NHS Foundation Trust\"),mdx(\"p\",null,`Chest imaging is increasingly used as an alternative method for\nscreening COVID-19, with high sensitivity compared to laboratory testing\nmethods. AI tools have the potential to enable fast and accurate\ndiagnosis from chest X-rays (CXR). However, several issues of image\nquality have been identified as a limitation to the diagnostic\nperformance of CXR, for example, in images acquired on portable\nmachines, and where under-exposure occurs due to patient positioning or\npatient BMI. Little is known about the impact of image-quality upon the\naccuracy and sensitivity of AI algorithms, and we propose to investigate\nthis, having been significantly involved in the development of the NCCID\ndatabase, and having successfully led previous evaluations of AI tools,\nfor example for diagnosis in breast screening.`),mdx(\"p\",null,`The aim of this study is to evaluate the impact of image quality on the\nperformance of AI models by analysing performance metrics during\ntraining and validation using the NCCID dataset. Published, open-source\nmodels shown to classify COVID-19 on CXR will be identified and the\nbest-performing algorithm selected by assessing performance on the NCCID\ntest dataset. The NCCID training and test datasets will be analysed\nusing existing image analysis tools developed in-house at RSNFT,\nenabling the categorisation of the NCCID dataset according to image\nquality, and the dataset will be stratified into datasets of different\nimage quality. The AI model will be retrained and tested on different\ncombinations of training and test data image-quality and the impact of\nimage-quality upon the accuracy and sensitivity of the model evaluated.`),mdx(\"h2\",null,\"Imperial College London\"),mdx(\"p\",null,`Sarcopenia is defined as the loss of skeletal muscle mass or function,\nis primarily a disease of the elderly and a marker of frailty.\nCurrently, physical fitness is assessed with performance status, however\nthis score is subject to interobserver variability. There is increasing\ninterest in the clinical importance of sarcopenia in a wide range of\nmalignancies such as lung, breast, upper GI and colorectal cancers,\nhowever the relationship to patient outcome in COVID-19 has not been\nevaluated. CT provides an objective and easily reproducible assessment\nof skeletal muscle which has been validated in cancer patients. These\nstudies used a time consuming manual segmentation of skeletal muscle at\nL3 (3rd lumbar vertebra level) which is not easily integrated into\npatient care and radiology reports. The research team have already\ndeveloped a fully automated technique for measuring sarcopenia on CT at\nL3. The aim of the study is to evaluate an objective fully automated\nassessment of muscle area and adiposity using artificial intelligence\n(AI) deep learning techniques on CT to determine whether these measures\nare linked to patient outcome in COVID-19 patients.`),mdx(\"h2\",null,\"University of Greenwich - School of Computing and Mathematical Sciences\"),mdx(\"p\",null,`The project deals with diagnosis of COVID-19 from chest CT scans, scan\nseries and x-rays, through a novel Deep Learning methodology. Its main\ntarget is to support unification of the rather fragmented field in UK\nand internationally, where projects train DL systems over specific\ndatasets, obtained in smaller local, or larger national frameworks, with\nno proof of good generalisation over different datasets and different\nclinical environments. It will achieve this through generation of a\nportable framework for COVID-19 diagnosis, based on analysis of\ninformation extracted from trained deep neural networks and adaptation\nacross different data cohorts and input modalities.`),mdx(\"p\",null,`In this framework, the main systems that have been trained with chest\nimaging examinations for diagnosis of COVID-19 in Greece will be tested\nand adapted to the UK cohort of CT scans and x-rays. It will be examined\nwhether the systems trained in a European country (such as Greece)\nperform also well when applied to data from UK patients. Either, or both\nCT scans and x-rays will be provided as inputs to these systems, for\nsingle modal, or multi-modal COVID-19 detection. Furthermore, it will be\ninvestigated whether this performance gets improved, if the systems get\nadapted to the UK cohort. Finally, a unification step will be\nimplemented, by merging both systems, i.e.,the original and the adapted\nones, also validating the good performance of the unified system on the\nUK data Cohort. This will illustrate the portability of the developed\nunified model across Greece and UK and will serve as pilot that can be\nextended with more COVID-19 diagnosis models from other parts of Europe,\nor elsewhere.`))}MDXContent.isMDXComponent=!0;\n","scope":{"title":"NCCID Project Summaries","summary":"The core of the NCCID initiative is to provide value to the public in response to the COVID-19 crisis. For this reason, NCCID wishes to share information on how the data is being utilised by approved institutions and researcherts, to inform the wider community of patients, staff and interested public.","category":"Other Information"}},"meta":{"title":"NCCID Project Summaries","summary":"The core of the NCCID initiative is to provide value to the public in response to the COVID-19 crisis. For this reason, NCCID wishes to share information on how the data is being utilised by approved institutions and researcherts, to inform the wider community of patients, staff and interested public.","category":"Other Information"}},"__N_SSG":true}